Total Payments
$17,341
2024 Payments
$1,530
Companies
48
Transactions
1,405
Medicare Patients
713
Medicare Billing
$90,973
Payment Breakdown by Category
Food & Beverage$17,175 (99.0%)
Education$166.23 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,175 | 1,395 | 99.0% |
| Education | $166.23 | 10 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,085 | 191 | $0 (2024) |
| Novo Nordisk Inc | $2,180 | 214 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,690 | 99 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,578 | 124 | $0 (2024) |
| Lilly USA, LLC | $1,353 | 142 | $0 (2024) |
| Merck Sharp & Dohme LLC | $949.35 | 105 | $0 (2024) |
| Astellas Pharma US Inc | $703.99 | 43 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $671.03 | 66 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $560.44 | 50 | $0 (2024) |
| Amarin Pharma Inc. | $513.20 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,530 | 95 | Boehringer Ingelheim Pharmaceuticals, Inc. ($270.39) |
| 2023 | $1,976 | 127 | Novo Nordisk Inc ($344.96) |
| 2022 | $1,957 | 120 | Novo Nordisk Inc ($471.50) |
| 2021 | $1,673 | 111 | Boehringer Ingelheim Pharmaceuticals, Inc. ($216.16) |
| 2020 | $1,482 | 114 | AstraZeneca Pharmaceuticals LP ($396.74) |
| 2019 | $2,506 | 232 | AstraZeneca Pharmaceuticals LP ($535.92) |
| 2018 | $2,762 | 238 | AstraZeneca Pharmaceuticals LP ($784.06) |
| 2017 | $3,456 | 368 | AstraZeneca Pharmaceuticals LP ($776.37) |
All Payment Transactions
1,405 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Endocrinology | ||||||
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardio-renal | ||||||
| 11/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Biological | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: DIABETES | ||||||
| 10/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.36 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Diabetes Care | ||||||
| 10/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.55 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardio-renal | ||||||
| 10/03/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: ANTI-DIABETIC | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 154 | 310 | $88,432 | $22,184 |
| 2022 | 4 | 171 | 332 | $90,152 | $23,629 |
| 2021 | 6 | 193 | 371 | $101,601 | $26,832 |
| 2020 | 5 | 195 | 349 | $86,809 | $18,327 |
Total Patients
713
Total Services
1,362
Medicare Billing
$90,973
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 234 | $75,582 | $18,248 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 50 | $10,900 | $2,603 | 23.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 13 | 13 | $1,170 | $935.09 | 79.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $780.00 | $398.19 | 51.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 228 | $73,644 | $18,295 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 61 | $13,298 | $3,266 | 24.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 21 | $1,890 | $1,439 | 76.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $1,320 | $628.32 | 47.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 243 | $78,489 | $20,008 | 25.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 71 | $15,478 | $3,534 | 22.8% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 22 | 22 | $2,024 | $1,461 | 72.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $3,900 | $912.20 | 23.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 11 | 11 | $990.00 | $709.30 | 71.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $720.00 | $207.74 | 28.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 80 | 201 | $64,923 | $12,977 | 20.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 77 | $16,786 | $2,917 | 17.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 28 | 28 | $2,520 | $1,701 | 67.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 31 | 31 | $1,860 | $528.49 | 28.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 12 | 12 | $720.00 | $202.80 | 28.2% |
About Dr. Kevin Longshaw, MD
Dr. Kevin Longshaw, MD is a Family Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013942374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Longshaw, MD has received a total of $17,341 in payments from pharmaceutical and medical device companies, with $1,530 received in 2024. These payments were reported across 1,405 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($17,175).
As a Medicare-enrolled provider, Longshaw has provided services to 713 Medicare beneficiaries, totaling 1,362 services with total Medicare billing of $90,973. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Dallas, TX
- Active Since 07/12/2006
- Last Updated 06/09/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1013942374
Products in Payments
- FARXIGA (Drug) $2,008
- JARDIANCE (Drug) $1,251
- Ozempic (Drug) $724.02
- TRELEGY ELLIPTA (Drug) $680.61
- Vascepa (Drug) $513.20
- JANUVIA (Drug) $422.50
- XARELTO (Drug) $406.96
- ANORO (Drug) $393.25
- TRULICITY (Drug) $379.83
- BEVESPI AEROSPHERE (Drug) $379.66
- Rybelsus (Drug) $351.80
- Saxenda (Drug) $351.06
- MOUNJARO (Drug) $295.75
- Kerendia (Drug) $287.28
- BELSOMRA (Drug) $281.47
- EMGALITY (Drug) $279.46
- FREESTYLE LIBRE 3 (Device) $275.60
- Myrbetriq (Drug) $273.14
- SYMBICORT (Drug) $267.13
- INVOKANA (Drug) $264.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dallas
Dr. Joe Blumenau, M.d., F.a.a.f.p, M.D., F.A.A.F.P
Family Medicine — Payments: $437,740
Family Medicine $437,740
Chrisette Dharmagunaratne, M.d, M.D
Family Medicine — Payments: $325,780
Family Medicine $325,780
Scott Conard, Md, MD
Family Medicine — Payments: $152,327
Family Medicine $152,327
Andrew Applewhite, Md, MD
Family Medicine — Payments: $83,645
Family Medicine $83,645
Shiwali Rai, Md, MD
Family Medicine — Payments: $43,143
Family Medicine $43,143
Dr. Paul Worrell, D.o, D.O
Family Medicine — Payments: $36,341
Family Medicine $36,341